v3.25.4
Statements of Changes in Convertible Preferred Stock and Stockholders’ Deficit - USD ($)
$ in Thousands
Total
Conversion of redeemable convertible preferred stock into common stock on completion of IPO
Conversion of redeemable convertible preferred stock warrants to common stock warrants on IPO
Conversion of convertible notes into common stock on completion of IPO
IPO
Common Stock
Common Stock
Conversion of redeemable convertible preferred stock into common stock on completion of IPO
Common Stock
Conversion of convertible notes into common stock on completion of IPO
Common Stock
IPO
Additional Paid-in Capital
Additional Paid-in Capital
Conversion of redeemable convertible preferred stock into common stock on completion of IPO
Additional Paid-in Capital
Conversion of redeemable convertible preferred stock warrants to common stock warrants on IPO
Additional Paid-in Capital
Conversion of convertible notes into common stock on completion of IPO
Additional Paid-in Capital
IPO
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance at Dec. 31, 2023 $ 74,475                              
Ending balance at Dec. 31, 2024 74,475                              
Beginning balance (in shares) at Dec. 31, 2023           57,354                    
Beginning balance at Dec. 31, 2023 (39,737)         $ 1       $ 1,328         $ 356 $ (41,422)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Issuance of common stock (in shares)           26,528                    
Issuance of common stock 66                 66            
Stock-based compensation expense 754                 754            
Net Loss (15,619)                             (15,619)
Other Comprehensive loss, net $ (159)                           (159)  
Ending balance (in shares) at Dec. 31, 2024 83,882         83,882                    
Ending balance at Dec. 31, 2024 $ (54,695)         $ 1       2,148         197 (57,041)
Increase (Decrease) in Temporary Equity [Roll Forward]                                
Issuance of preferred stock in private placement, net of issuance cost 51,445                              
Exercise of preferred stock warrant 1,044                              
Conversion of preferred stock to common stock upon IPO (126,964)                              
Ending balance at Dec. 31, 2025 0                              
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                
Conversion of convertible securities (in shares)             12,366,434 2,810,428                
Conversion of convertible securities   $ 126,964 $ 637 $ 42,156     $ 12 $ 3     $ 126,952 $ 637 $ 42,153      
Issuance of common stock (in shares)           347,999     5,000,000              
Issuance of common stock $ 919       $ 64,212       $ 5 919       $ 64,207    
Exercise of common stock warrants (in shares) 14,714         14,714                    
Stock-based compensation expense $ 996                 996            
Net Loss (40,359)                             (40,359)
Other Comprehensive loss, net $ (80)                           (80)  
Ending balance (in shares) at Dec. 31, 2025 20,623,457         20,623,457                    
Ending balance at Dec. 31, 2025 $ 140,750         $ 21       $ 238,012         $ 117 $ (97,400)